MiniMed Group (MMED) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
9 Oct, 2026Opening remarks and agenda
Meeting convened with a quorum: 278,485,985 of 281,349,931 shares outstanding were represented in person or by proxy.
Four proposals covered Class I director elections, PwC ratification for FY2027, an advisory vote on executive compensation, and the frequency of future say-on-pay votes.
Board and executive committee updates
Kevin Lofton chaired the meeting; directors, CEO Que Dallara, CFO Chad Spooner, General Counsel and Corporate Secretary Sheila Denton, and PwC representatives attended.
Kevin Lofton, David Endicott, D. Keith Grossman, and Timothy Wicks were nominated for election as Class I directors.
Overview of voting outcomes
Preliminary results showed all four proposals passed, including the director elections, auditor ratification, executive compensation vote, and one-year frequency for future say-on-pay votes.
Final results were to be reported in an SEC Form 8-K within four business days of the meeting.
Latest events from MiniMed Group
- Accelerating innovation and global scale drive durable growth, with Vivera set to transform diabetes care.MMED
Bank of America Global Healthcare Conference - Revenue up 16.6% to $843M, with strong pump and CGM growth and improved profitability.MMED
Q2 2026 - New product launches and upcoming innovations drive growth and market expansion, especially for Type 2.MMED
Wells Fargo 21st Annual Healthcare Conference - Strong growth, innovation, and clinical outcomes drive robust financials and global expansion.MMED
Investor presentation - Q1 FY27 delivered 16% organic revenue growth and raised full-year guidance to 10.5%.MMED
Q1 2027 - Annual meeting to vote on directors, auditor, and executive pay, all board-recommended.MMED
Proxy filing - Proxy covers director elections, auditor ratification, and executive pay post-separation.MMED
Proxy filing - AID market growth accelerates with new launches, integrated tech, and global execution focus.MMED
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Innovation and global scale fuel strong growth, margin expansion, and clinical leadership.MMED
Investor presentation